Insulin Therapy, Insulin Resistance and Vascular Dysfunction

Curr Vasc Pharmacol. 2019;17(5):429-431. doi: 10.2174/157016111705190703103110.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Vessels / drug effects*
  • Blood Vessels / metabolism
  • Blood Vessels / physiopathology
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / epidemiology
  • Diabetes Mellitus / metabolism
  • Diabetes Mellitus / physiopathology
  • Diabetic Angiopathies / drug therapy*
  • Diabetic Angiopathies / epidemiology
  • Diabetic Angiopathies / metabolism
  • Diabetic Angiopathies / physiopathology
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance*
  • Insulin-Secreting Cells / drug effects*
  • Insulin-Secreting Cells / metabolism
  • Risk Factors
  • Treatment Outcome

Substances

  • Hypoglycemic Agents